Replies to post #520631 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

I’m sure NWBO was busy telling investors from 8 to 20 years ago that they were investing at the wrong time.

Oh wait! They were talking about the “1 yard line” paying for promotional spots and even getting on Fox Business.

So it takes two to tango and that is why the deliberate stringing along and dangling carrots like HE is especially annoying as is the false sense of imminence being cultivated yet again.

The company does not even at least to our knowledge have to pay for it anymore.

[Poor Man -]

First, why flying saucers appear above the heads of LP and the others is just another mystery to solve. I guess?

I would be interested to know the source for your claim below, and also know what the average cost per patient is to bring a drug to market. NWBO has spent approximate $3 million per patient in its own trial. Is that anywhere in the normal range? — seems extremely high to me.

Jammy, 15 years and $2 Billion dollars is the average for a pharma to bring a drug to market is . Anyone who invested 10-15 years ago was an uhmm...an "early adopter".. yeah. they invested too soo and now complain about their poor timing. The management is just going with industry averages, and, it was/is a very new area of research. Lots of discoveries that required adaptation in the trial, such as dealing with psuedoprogression. See twitter video of an Expert saying 15 years and $2 billion.